Evidence map›Paper›PMID 31900938›Full record

ArticleBritish journal of pharmacology2020

Melatonin up-regulates bone marrow mesenchymal stem cells osteogenic action but suppresses their mediated osteoclastogenesis via MT

Yi Zhou, Chaowei Wang, Jinyan Si, Baixiang Wang, Denghui Zhang, Ding Ding, Jian Zhang, Huiming Wang

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Molecular and Cellular Mechanisms of Osteoporosis.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yi ZhouThe Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0001-8330-7363
Chaowei WangThe Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jinyan SiThe Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Baixiang WangThe Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Denghui ZhangThe Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ding DingThe Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jian ZhangDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Huiming WangThe Affiliated Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhejiang University Medical College Affiliated Stomatological Hospital · CNFirst Affiliated Hospital Zhejiang University · CN

Funding

National Natural Science Foundation of China 31671763National Natural Science Foundation of China 81600909National Natural Science Foundation of China 81801640National Natural Science Foundation of Zhejiang Province of China Y19H140018
6 · The paper itself

Abstract

background and purposeMelatonin is a neurohormone involved in bone homeostasis. Melatonin directs bone remodelling and the role of bone marrow mesenchymal stem cells (BMMSCs) in the regulating melatonin-mediated bone formation-resorption balance remains undefined. EXPERIMENTAL APPROACH: Osteoporosis models were established and bone tissue and serum were collected to test the effects of melatonin on bone homeostasis. Melatonin receptors were knocked down, the NF-κB signalling pathway and receptor activator of NF-κB ligand (RANKL) expression were investigated. Communication between bone marrow mesenchymal stem cells and osteoclasts was detected with direct-contact or indirect-contact system. KEY

resultsBone loss and microstructure disorder in mice were reversed after melatonin treatment, as a result of anabolic and anti-resorptive effects. In vitro, a physiological (low) concentration of melatonin promoted the bone marrow mesenchymal stem cells, osteogenic lineage commitment and extracellular mineralization but had no impact on extracellular matrix synthesis. After MT knockdown, especially MT CONCLUSION AND IMPLICATIONS: Our work suggests that melatonin plays a crucial role in bone balance, significantly accelerates the osteogenic differentiation of bone marrow mesenchymal stem cells by suppressing the MT

Indexed as

Bone ResorptionMelatoninMesenchymal Stem CellsAnimalsBone Marrow CellsCell DifferentiationMiceNF-kappa BOsteoclastsOsteogenesisRANK LigandMelatoninNF-kappa BRANK Ligand

Identifiers

PMID31900938
PMCPMC7161576
OpenAlexW2998183920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.